Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD

被引:12
作者
Xie, Ziyan [1 ]
Xie, Ting [1 ,2 ]
Liu, Jieying [1 ,2 ]
Zhang, Qian [1 ]
Xiao, Xinhua [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Endocrinol, Key Lab Endocrinol,Min Health, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Med Res Ctr, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
O-GlcNAc; post-translational modification; liver metabolism; insulin resistance; diabetes; NAFLD; HEXOSAMINE BIOSYNTHETIC-PATHWAY; N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; X-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; GLUCOSE-METABOLISM; GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; INSULIN-RESISTANCE; GENE-EXPRESSION; FOXO1; INCREASES;
D O I
10.3390/ijms24032142
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
O-linked b-N-acetyl-glucosaminylation (O-GlcNAcylation) is one of the most common post-translational modifications of proteins, and is established by modifying the serine or threonine residues of nuclear, cytoplasmic, and mitochondrial proteins. O-GlcNAc signaling is considered a critical nutrient sensor, and affects numerous proteins involved in cellular metabolic processes. O-GlcNAcylation modulates protein functions in different patterns, including protein stabilization, enzymatic activity, transcriptional activity, and protein interactions. Disrupted O-GlcNAcylation is associated with an abnormal metabolic state, and may result in metabolic disorders. As the liver is the center of nutrient metabolism, this review provides a brief description of the features of the O-GlcNAc signaling pathway, and summarizes the regulatory functions and underlying molecular mechanisms of O-GlcNAcylation in liver metabolism. Finally, this review highlights the role of O-GlcNAcylation in liver-associated diseases, such as diabetes and nonalcoholic fatty liver disease (NAFLD). We hope this review not only benefits the understanding of O-GlcNAc biology, but also provides new insights for treatments against liver-associated metabolic disorders.
引用
收藏
页数:19
相关论文
共 127 条
[21]   Hepatic glucose sensing via the CREB coactivator CRTC2 [J].
Dentin, Renaud ;
Hedrick, Susan ;
Xie, Jianxin ;
Yates, John, III ;
Montminy, Marc .
SCIENCE, 2008, 319 (5868) :1402-1405
[22]   Decreased O-GlcNAcylation of the key proteins in kinase and redox signalling pathways is a novel mechanism of the beneficial effect of α-lipoic acid in diabetic liver [J].
Dinic, Svetlana ;
Arambasic, Jelena ;
Mihailovic, Mirjana ;
Uskokovic, Aleksandra ;
Grdovic, Nevena ;
Markovic, Jelena ;
Karadzic, Borivoje ;
Poznanovic, Goran ;
Vidakovic, Melita .
BRITISH JOURNAL OF NUTRITION, 2013, 110 (03) :401-412
[23]   Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans [J].
Duggirala, R ;
Blangero, J ;
Almasy, L ;
Dyer, TD ;
Williams, KL ;
Leach, RJ ;
O'Connell, P ;
Stern, MP .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (04) :1127-1140
[24]   AMP-activated protein kinase phosphorylates glutamine : fructose-6-phosphate amidotransferase 1 at Ser243 to modulate its enzymatic activity [J].
Eguchi, Satoshi ;
Oshiro, Noriko ;
Miyamoto, Takafumi ;
Yoshino, Ken-ichi ;
Okamoto, Sumiko ;
Ono, Takamasa ;
Kikkawa, Ushio ;
Yonezawa, Kazuyoshi .
GENES TO CELLS, 2009, 14 (02) :179-189
[25]   LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice [J].
Fan, Qiong ;
Norgaard, Rikke C. ;
Bindesboll, Christian ;
Lucas, Christin ;
Dalen, Knut Tomas ;
Babaie, Eshrat ;
Itkonen, Harri M. ;
Matthews, Jason ;
Nebb, Hilde I. ;
Gronning-Wang, Line M. .
NUTRIENTS, 2017, 9 (07)
[26]   O-GlcNAcylation: a new cancer hallmark? [J].
Fardini, Yann ;
Dehennaut, Vanessa ;
Lefebvre, Tony ;
Issad, Tarik .
FRONTIERS IN ENDOCRINOLOGY, 2013, 4
[27]   Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation [J].
Farzanegi, Parvin ;
Dana, Amir ;
Ebrahimpoor, Zeynab ;
Asadi, Mahdieh ;
Azarbayjani, Mohammad Ali .
EUROPEAN JOURNAL OF SPORT SCIENCE, 2019, 19 (07) :994-1003
[28]   O-GlcNAcylated p53 in the liver modulates hepatic glucose production [J].
Gonzalez-Rellan, Maria J. ;
Fondevila, Marcos F. ;
Fernandez, Uxia ;
Rodriguez, Amaia ;
Varela-Rey, Marta ;
Veyrat-Durebex, Christelle ;
Seoane, Samuel ;
Bernardo, Ganeko ;
Lopitz-Otsoa, Fernando ;
Fernandez-Ramos, David ;
Bilbao, Jon ;
Iglesias, Cristina ;
Novoa, Eva ;
Ameneiro, Cristina ;
Senra, Ana ;
Beiroa, Daniel ;
Cunarro, Juan ;
Chantada-Vazquez, Maria D. P. ;
Garcia-Vence, Maria ;
Bravo, Susana B. ;
Da Silva Lima, Natalia ;
Porteiro, Begona ;
Carneiro, Carmen ;
Vidal, Anxo ;
Tovar, Sulay ;
Muller, Timo D. ;
Ferno, Johan ;
Guallar, Diana ;
Fidalgo, Miguel ;
Sabio, Guadalupe ;
Herzig, Stephan ;
Yang, Won Ho ;
Cho, Jin Won ;
Luz Martinez-Chantar, Maria ;
Perez-Fernandez, Roman ;
Lopez, Miguel ;
Dieguez, Carlos ;
Mato, Jose M. ;
Millet, Oscar ;
Coppari, Roberto ;
Woodhoo, Ashwin ;
Fruhbeck, Gema ;
Nogueiras, Ruben .
NATURE COMMUNICATIONS, 2021, 12 (01)
[29]   Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects [J].
Graham, Timothy E. ;
Yang, Qin ;
Blueher, Matthias ;
Hammarstedt, Ann ;
Ciaraldi, Theodore P. ;
Henry, Robert R. ;
Wason, Christopher J. ;
Oberbach, Andreas ;
Jansson, Per-Anders ;
Smith, Ulf ;
Kahn, Barbara B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (24) :2552-2563
[30]   O-G1cNAcylation Increases ChREBP Protein Content and Transcriptional Activity in the Liver [J].
Guinez, Celine ;
Filhoulaud, Gaelle ;
Rayah-Benhamed, Fadila ;
Mannier, Solenne ;
Dubuquoy, Celine ;
Dentin, Renaud ;
Moldes, Marthe ;
Burnol, Anne-Francoise ;
Yang, Xiaoyong ;
Lefebvre, Tony ;
Girard, Jean ;
Postic, Catherine .
DIABETES, 2011, 60 (05) :1399-1413